Cafepharma Today

September 19 2024 - Novartis not joining the ‘frenzy’ of weight loss drugs, CEO says
Novartis not joining the ‘frenzy’ of weight loss drugs, CEO says
Havas Lynx explores pharma marketers’ role in addressing climate health crisis
Roche reports positive data from Phase III influenza treatment trial
ICER mulls GSK COPD drugs ahead of next Medicare negotiation
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

Caris Raises Wyeth to Above Average: “Port in a Storm”
Barron's
Wednesday, September 17, 2008 - 12:56pm
tags:
Abbott & Boston Scientific: Rising Stent Stars
CNBC
Wednesday, September 17, 2008 - 12:55pm
tags:
Glaxo and Roche await FDA nod on new drugs
Trading Markets
Wednesday, September 17, 2008 - 10:04am
tags:
Wall Street brushes off delay on Gilead Sciences' cystic fibrosis candidate, setback is minor
Yahoo/AP
Wednesday, September 17, 2008 - 10:02am
tags:
Valeant Pharmaceuticals paying $95 million for Coria Laboratories in product expansion move
Yahoo/AP
Wednesday, September 17, 2008 - 10:01am
tags:
Small Swedish Pharma Could Be Buyout Target for Pfizer
WSJ Online
Wednesday, September 17, 2008 - 10:00am
tags:
GSK Restructures Oncology Division
PharmExec
Wednesday, September 17, 2008 - 9:59am
tags:
U.S. Merck's Japan unit to slash sales branches
Yahoo/Reuters
Wednesday, September 17, 2008 - 6:16am
tags:
Targacept shares fall to all-time low on disappointing Alzheimer's disease drug study
Yahoo/AP
Wednesday, September 17, 2008 - 6:15am
tags:
Karo Bio Study Boosts Buyout Prospects From Pfizer
Bloomberg
Wednesday, September 17, 2008 - 6:14am
tags:
Reshuffle costs Sanofi-Aventis €17m
FT.com
Tuesday, September 16, 2008 - 8:52pm
tags:
FDA says No to Gilead cystic fibrosis drug
Bizjournals.com
Tuesday, September 16, 2008 - 8:51pm
tags:
Ranbaxy Imports of 30 Drugs Will Be Barred, U.S. Says
Bloomberg
Tuesday, September 16, 2008 - 8:50pm
tags:
Pfizer Puts Safety First
Motley Fool
Tuesday, September 16, 2008 - 4:12pm
tags:
Eli Lilly downgraded to 'Underweight' on key patent expirations and early-stage pipeline
Yahoo/AP
Tuesday, September 16, 2008 - 4:12pm
tags:
Pharmaceutical shares dip slightly after Federal reserve leaves interest rate unchanged
Yahoo/AP
Tuesday, September 16, 2008 - 2:53pm
tags:
Is Pharma Still a Safe Investment?
Motley Fool
Tuesday, September 16, 2008 - 2:52pm
tags:
Amgen Rises on Bone-Drug Data
The Street.com
Tuesday, September 16, 2008 - 2:51pm
tags:
Trading Calls on Lilly's Volatility
Barron's
Tuesday, September 16, 2008 - 2:50pm
tags:
Sciele Pharma says glycopyrrolate met goal of reducing pediatric drooling in late-stage trial
Yahoo/AP
Tuesday, September 16, 2008 - 2:49pm
tags:

Pages

Latest CP Wire Articles

PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business
Bend Bioscience Adds Capacity and Technology Offerings with the Addition of New Process and Manufacturing Science Facility
Eastman introduces new excipient to formulate poorly soluble API

Latest Pharmagather Articles

FDA Approves Fasenra for Eosinophilic Granulomatosis with Polyangiitis
pharmexec
FDA Approves Keytruda Plus Pemetrexed, Platinum Chemotherapy for Unresectable Advanced or Metastatic Malignant Pleural Mesothelioma
pharmexec
Keytruda Demonstrates Superior Overall Survival vs. Yervoy in Advanced Melanoma
pharmexec
CAR-T For Autoimmune Disorders
In the Pipeline
A Better Response to Inflammation: Q&A with Dr. Ira Spector
pharmexec
Braftovi Plus Mektovi Demonstrates Sustained Efficiency in Patients with BRAF V600E-Mutant Metastatic Non-Small Cell Lung Cancer
pharmexec
GSK Launches Brooke Shields’ Led Campaign Promoting Shingles Vaccine
pharmexec
Pharma Pulse: 9/18/24: How Drug Shortages Affect Pharmacovigilance, Long Strange Trip Continues for Psychedelics & more
pharmexec
Pharmaceutical Executive: September 2024 Issue (PDF)
pharmexec

Latest Jobs

Account Manager-Los Angeles-Ophthalmics
Los Angeles, California, 90079
Sun Pharmaceutical Industries, Inc.
Regional Sales Manager - Eyecare - East Region
Miami, Florida, 33222
PV8 US Innovex Inc.
Business Development Manager- Tampa, Florida
Tampa, Florida, 33646
Hanger Clinic
Neuroscience Account Manager (Psychiatry) - Burbank, CA
Burbank, California, 91520
Vanda Pharmaceuticals
Territory Account Associate- Grand Rapids, MI
Grand Rapids, Michigan, 49528
Amplity Health
Surgical Solutions Field Sales Associate - Remote
Milwaukee, Wisconsin, 53244
W.L. Gore & Associates
Manager, Business Development - Physician Relations - Days - Full-Time
Baton Rouge, Louisiana, 70873
Woman's Hospital
Area Business Manager - Pulmonology - Greenville, SC
Asheville, North Carolina, 28814
Sanofi
Area Manager, Specialty Atlantic Region
Fields, Oregon, 97710
CSL Behring
Territory Manager (PCP) (Madison, AL)
Huntsville, Alabama, 35824
Bausch Health
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information